Aelius Biotech announced that it has raised £1.25 million in a round of funding on November 23, 2023. The transaction included participation from new investors North East Venture Fund, a fund co-managed by Mercia Fund Management Ltd. and Mercia Asset Management PLC.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
33.2 GBX | -0.90% | -3.21% | +9.93% |
Chiffre d''affaires - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.93% | 182M | |
-0.18% | 95.63B | |
+28.73% | 90.91B | |
+24.27% | 28.22B | |
+0.28% | 18.26B | |
+17.21% | 15.8B | |
+7.73% | 15.22B | |
-17.88% | 12.85B | |
+17.38% | 9.4B | |
+26.51% | 9.28B |
- Stock Market
- Equities
- MERC Stock
- News Mercia Asset Management PLC
- Aelius Biotech announced that it has received £1.25 million in funding from Mercia Fund Management Ltd., Mercia Asset Management PLC